Insmed
INSM | NASDAQ
$121
+$1 (+0.83%)
At close: Sep 21, 2026, 4:00 PM ET
$122.45
+$1.45 (+1.20%)
Pre-market:
Sep 22, 2026, 4:16 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 606.42M | 363.71M | 305.21M | 245.36M | 188.46M | 164.41M |
Cost of Revenue | 124.88M | 85.74M | 65.57M | 55.13M | 44.15M | 39.87M |
Gross Profit | 481.55M | 277.97M | 239.64M | 190.23M | 144.31M | 124.54M |
Operating Income | -1.18B | -878.25M | -709.63M | -457.32M | -375.09M | -265.23M |
Interest Income | 60.66M | 53.31M | 42.13M | 11.08M | 174K | 1.7M |
Pretax Income | -1.27B | -910.07M | -747.01M | -480.15M | -436.41M | -292.69M |
Net Income | -1.28B | -913.77M | -749.57M | -481.53M | -434.65M | -294.09M |
Selling & General & Admin | 701.17M | 461.12M | 344.5M | 265.78M | 234.27M | 203.61M |
Research & Development | 771.09M | 598.37M | 571.01M | 397.52M | 272.74M | 181.16M |
Other Expenses | 186.02M | 96.73M | 33.75M | -15.75M | 12.39M | 5M |
Operating Expenses | 1.66B | 1.16B | 949.26M | 647.55M | 519.4M | 389.77M |
Interest Expense | 83.8M | 84.91M | 81.69M | 26.45M | 40.47M | 29.56M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.78B | 1.24B | 1.01B | 702.68M | 563.56M | 429.65M |
Income Tax Expense | 5.03M | 3.71M | 2.56M | 1.38M | -1.76M | 1.4M |
Shares Outstanding (Basic) | 213.64M | 164.04M | 140.43M | 123.04M | 112.11M | 97.61M |
Shares Outstanding (Diluted) | 213.64M | 164.04M | 140.43M | 123.04M | 112.11M | 97.61M |
EPS (Basic) | -6.41 | -5.57 | -5.34 | -3.91 | -3.88 | -3.01 |
EPS (Diluted) | -6.41 | -5.57 | -5.34 | -3.91 | -3.88 | -3.01 |
EBITDA | -1.17B | -818.79M | -660.18M | -447.37M | -383.65M | -250.37M |
EBIT | -1.19B | -829.81M | -670.76M | -457.7M | -397.83M | -264.52M |
Depreciation & Amortization | 16.45M | 11.01M | 10.58M | 10.33M | 14.18M | 14.15M |
Add to Watchlist
Select watchlists to add or remove INSM